TP53 and breast carcinoma: The same investigators found the SNP309G allele to be associated with early onset of several malignancies among individuals carrying TP53 germline mutations (Li-Fraumeni syndrome) and also lower age at diagnosis of estrogen receptor (ER) rich breast cancer among individuals with wild-type TP53 [9, 8].